Inventor · disambiguated record
Graham Beaton
Also filed as: BEATON GRAHAM
25 granted patents·7 pending applications·1,476 citations·filing 1994–2025
95Inventor score
Files withCURTANA PHARMACEUTICALS INC9NEUROCRINE BIOSCIENCES INC8EPIGEN BIOSCIENCES INC7BEATON GRAHAM4BRUIN BIOSCIENCES INC2
Top patents by PatentIndex Score
32 records- 0195US5625050AModified oligonucleotides and intermediates useful in nucleic acid therapeuticsAMGEN INC·Filed 1994·Granted Apr 29, 1997·1.4k cites·2 claims
- 0294US9422310B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2015·Granted Aug 23, 2016·14 cites·19 claims
- 0389US8084614B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Dec 27, 2011·12 cites·17 claims
- 0485US10941159B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 0585US8481738B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 0683US10570103B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2018·Granted Feb 25, 2020·3 cites·24 claims
- 0783US10336769B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Jul 2, 2019·2 cites·1 claims
- 0883US8952161B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2013·Granted Feb 10, 2015·4 cites·16 claims
- 0982US10227333B2Inhibition of OLIG2 activityCURTANA PHARMACEUTICALS INC·Filed 2016·Granted Mar 12, 2019·3 cites·15 claims
- 1082US6924284B2PARP inhibitorsDELTAGEN RES LABS LLC·Filed 2002·Granted Aug 2, 2005·42 cites·55 claims
- 1176US11713324B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Aug 1, 2023·0 cites·2 claims
- 1276US2025282792A1Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1375US12234224B2Pyrimidine and pyridine amine compounds and usage thereof in disease treatmentEPIGEN BIOSCIENCES INC·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 1475US2023271926A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1570US12357570B2Chemoembolization agentsBRUIN BIOSCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·18 claims
- 1668US11691951B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·8 claims
- 1767US12145913B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Nov 19, 2024·0 cites·6 claims
- 1867US11427552B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2020·Granted Aug 30, 2022·0 cites·20 claims
- 1965US2021114991A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2063US11866421B2Pyrimidine and pyridine amine compounds and usage thereof in disease treatmentEPIGEN BIOSCIENCES INC·Filed 2021·Granted Jan 9, 2024·0 cites·21 claims
- 2163US2023286928A1Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2262US10526298B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2018·Granted Jan 7, 2020·0 cites·47 claims
- 2361US10000459B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2014·Granted Jun 19, 2018·0 cites·19 claims
- 2458US11712418B2Chemoembolization agentsBRUIN BIOSCIENCES INC·Filed 2018·Granted Aug 1, 2023·0 cites·12 claims
- 2556US8263588B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Sep 11, 2012·0 cites·18 claims
- 2653US11242323B2Inhibition of OLIG2 activityCURTANA PHARMACEUTICALS INC·Filed 2017·Granted Feb 8, 2022·0 cites·15 claims
- 2753US2023321094A1Combination therapies with olig2 inhibitorsCURTANA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2848US8507536B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2012·Granted Aug 13, 2013·0 cites·16 claims
- 2948US2018244631A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3047US11685722B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2019·Granted Jun 27, 2023·0 cites·14 claims
- 3143US7393865B2Sleep inducing compounds and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jul 1, 2008·0 cites·16 claims
- 3240US2005277645A1Sleep inducing compounds and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Graham Beaton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →